Arena Pharmaceuticals, Inc. (ARNA) Stock Falls -2.30% This Week: Is It a Good Pick?

Tuesday, January 25, 2022 10:53 AM | InvestorsObserver Analysts

Mentioned in this article

Arena Pharmaceuticals, Inc. (ARNA) Stock Falls -2.30% This Week: Is It a Good Pick?

Arena Pharmaceuticals, Inc. (ARNA) stock is higher by 15.21% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ARNA stock a score of 68 out of a possible 100. That rank is chiefly influenced by a long-term technical score of 99. ARNA's rank also includes a short-term technical score of 96. The fundamental score for ARNA is 8. In addition to the average rating from Wall Street analysts, ARNA stock has a mean target price of $96.38. This means analysts expect the stock to climb 7.25% over the next 12 months.

ARNA has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ARNA!

See Full ARNA Report

What's Happening with ARNA Stock Today

Arena Pharmaceuticals, Inc. (ARNA) stock has fallen -0.1% while the S&P 500 is down -1.4% as of 10:51 AM on Tuesday, Jan 25. ARNA is down -$0.09 from the previous closing price of $89.95 on volume of 198,647 shares. Over the past year the S&P 500 is up 12.79% while ARNA is higher by 15.21%. ARNA lost -$9.69 per share in the over the last 12 months. Click Here to get the full Stock Report for Arena Pharmaceuticals, Inc. stock.